Assessing the validity, responsiveness and reliability of the RECAP measure of eczema control

Alisha Bhanot, TJ Peters, Matthew J Ridd*

*Corresponding author for this work

Research output: Contribution to journal › Article (Academic Journal) › peer-review

15 Citations (Scopus)
118 Downloads (Pure)

Abstract

Research comparing the effectiveness of different eczema treatments is limited by inconsistency in both outcomes assessed and the measures used. HOME (Harmonising Outcome Measures for Eczema) recommends a core set of outcomes to be reported in all trials of eczema treatments.1 RECAP (RECap for AtoPic eczema) is a seven‐item patient‐reported instrument recommended for capturing eczema control.2 Initial validation work is encouraging, but RECAP’s validity in different populations and the reliability and responsiveness is uncertain.2,3
Original languageEnglish
Number of pages2
JournalBritish Journal of Dermatology
Early online date3 Dec 2020
DOIs
Publication statusPublished - 1 May 2021

Access to Document

  • Full-text PDF (final published version)

    This is the final published version of the article (version of record). It first appeared online via Wiley at https://doi.org/10.1111/bjd.19709. Please refer to any applicable terms of use of the publisher.

    Final published version, 85 KBLicence: CC BY

Handle.net

    Embargoed Document

  • Full-text PDF (author accepted manuscript)

    Accepted author manuscript, 196 KB

Fingerprint

Dive into the research topics of 'Assessing the validity, responsiveness and reliability of the RECAP measure of eczema control'. Together they form a unique fingerprint.
View full fingerprint

Cite this